Relay Therapeutics, Inc.
RLAY
$3.69
$0.288.21%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 8.68% | -1.40% | 13.73% | 4.45% | -13.30% |
| Total Depreciation and Amortization | -17.05% | -9.45% | -2.41% | -0.07% | -1.94% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -9.63% | 15.47% | -20.48% | 58.68% | -43.91% |
| Change in Net Operating Assets | 87.34% | -1,140.79% | 118.94% | -159.57% | 60.99% |
| Cash from Operations | 24.52% | -26.51% | 22.93% | -14.05% | -30.82% |
| Capital Expenditure | 93.23% | -- | 100.00% | -1,963.64% | 99.38% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 75.43% | 47.77% | 123.03% | -376.41% | 270.08% |
| Cash from Investing | 76.96% | 46.44% | 122.98% | -376.97% | 332.53% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -99.63% | 14,095.14% | -96.85% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -99.63% | 14,095.14% | -96.85% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 166.80% | -9.53% | -259.09% | 194.15% | -305.27% |